2,3-disubstituted pyridine derivatives, process for the preparation thereof, drug compositions containing the same and intermediates for the preparation
CA 2345577 A1 · Owner: Itoh, Mari · Inventors: Itoh, Mari; Kawasaki, Motoji; Nakamura, Shunya
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Compounds represented by general formula (I) (wherein A is O S, CHR1 or NR2; , R1 and R2 are each H or lower alkyl; X1 and X2 are each H halogeno, nitro, cyano or the like; Y1 is H or lower alkyl; Z1 and Z2 are each H halogeno, cyano, hydroxy, lower alkyl or the like; and n is an integer of 2 to 4) and , physiologically acceptable salts thereof; a process for the preparation of both; drug compositions containing the same as the active ingredient; and intermediates for the preparation. The compounds (I) exhibit potent PDE IV inhibiting and excellent bronchodilating activities and are therefore useful , as PDE IV inhibitors and as therapeutic and preventive drugs for various allergic …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed September 30, 1999. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended September 30, 2019.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by September 30, 2021.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.